Maximilian Konig, MD
Rheumatology · Baltimore, MDNPI 1366897845
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $21,110 of the $23,081 with a category attached, or 91.5%. 8 manufacturers reported payments, led by Legend Biotech USA Inc. at 38.5% of the total. 2025 is the largest year on record at $18,292, more than ten times the $600 reported in 2019.
Across 26 payments — averaging $887.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Legend Biotech USA Inc.$9K
- E.r. Squibb & Sons, L.L.C.$7K
- AstraZeneca$3K
- Sanofi$2K
- Amgen$1K
- Celltrion Healthcare Co., Ltd$600
- plus $648 from 2 others
Across 3 payments — averaging $1564.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$5K
- E.r. Squibb & Sons, L.L.C.$145
What the payments were for
- Consulting fees$21,11091%
- Speaking & faculty fees$6003%
- Travel & lodging$9964%
- Food & beverage$3752%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Legend Biotech USA Inc. | 8 | $8,877 |
| E.r. Squibb & Sons, L.L.C. | 4 | $6,766 |
| AstraZeneca | 1 | $3,222 |
| Sanofi | 1 | $1,752 |
| Amgen | 1 | $1,216 |
| Celltrion Healthcare Co., Ltd | 1 | $600 |
| Bristol Myers Squibb | 9 | $598 |
| Novartis | 1 | $50 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$23,081 in reported general payments places this provider in the 80th percentile of 173 rheumatology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Baltimore
- Michelle PetriBaltimore$381K
- Marc HochbergBaltimore$124K
- Clifton BinghamBaltimore$117K
- Lisa ChristopherBaltimore$92K
- Philip SeoBaltimore$84K
- Laura HummersBaltimore$80K
- Rachel WallworkBaltimore$71K
- Thomas Grader BeckBaltimore$55K
- Andrea FavaBaltimore$38K
- Christopher MecoliBaltimore$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.